- Results Improved in All Segments -
- Q4 2025 Gross Profit of
President and Chief Executive Officer
“For the fourth quarter, gross profit reached
Financial Results for the Three Months Ended
- Net sales were
$232.0 million , compared to$236.3 million . - Cost of goods sold was
$216.8 million , compared to$237.7 million . - Gross profit was
$15.2 million , compared to a gross loss of$1.4 million . Gross profit included$1.9 million of realized derivative gains, compared to losses of$3.5 million . - Selling, general and administrative expenses were
$6.9 million , compared to$7.4 million . - Interest expense was
$2.4 million , compared to$2.5 million . - Net income attributable to common stockholders was
$21.5 million , or$0.28 per diluted share, compared to a net loss of$42.0 million , or$0.57 per share. - Adjusted EBITDA was
$27.9 million , compared to negative$7.7 million .
Financial Results for the Twelve Months Ended
- Net sales were
$917.9 million , compared to$965.3 million . - Cost of goods sold was
$883.0 million , compared to$955.5 million . - Gross profit was
$34.9 million , compared to$9.7 million . Gross profit included$10.7 million of realized derivative gains, compared to losses of$2.5 million . - Selling, general and administrative expenses were
$27.2 million , compared to$29.7 million . - Interest expense was
$10.8 million , compared to$7.6 million . - Net income attributable to common stockholders was
$12.1 million , or$0.16 per diluted share, compared to a net loss of$60.3 million , or$0.82 per share. - Adjusted EBITDA was
$44.7 million , compared to negative$8.5 million .
Cash and cash equivalents at
Fourth Quarter and Year-End 2025 Results Conference Call
Management will host a conference call at
To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.
Use of Non-GAAP Measures
Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.
About
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations of driving profitability and executing on opportunities to grow earnings, including enhancing and expanding its production capabilities, increasing renewable fuel exports, leveraging the demand for liquid CO2, and monetizing additional 45Z tax credits, including the Section 45Z tax credits for which
Company IR and Media Contact:
Investorrelations@altoingredients.com
IR Agency Contact:
Investorrelations@altoingredients.com
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited, in thousands, except per share data) | |||||||||||||||
| Three Months Ended | Years Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | 231,965 | $ | 236,347 | $ | 917,927 | $ | 965,258 | |||||||
| Cost of goods sold | 216,802 | 237,738 | 883,014 | 955,536 | |||||||||||
| Gross profit (loss) | 15,163 | (1,391 | ) | 34,913 | 9,722 | ||||||||||
| Selling, general and administrative expenses | (6,873 | ) | (7,358 | ) | (27,208 | ) | (29,736 | ) | |||||||
| Acquisition-related recoveries (expenses) | — | (5,676 | ) | 460 | (7,701 | ) | |||||||||
| Gain on sale of assets | — | — | — | 830 | |||||||||||
| Asset impairments | (803 | ) | (24,790 | ) | (803 | ) | (24,790 | ) | |||||||
| Income (loss) from operations | 7,487 | (39,215 | ) | 7,362 | (51,675 | ) | |||||||||
| Interest expense, net | (2,425 | ) | (2,474 | ) | (10,765 | ) | (7,644 | ) | |||||||
| Transferable tax credits, net | 7,500 | — | 7,500 | — | |||||||||||
| Excess insurance proceeds | 6,688 | — | 6,688 | — | |||||||||||
| Other income, net | 1,935 | 150 | 1,932 | 508 | |||||||||||
| Income (loss) before (benefit) provision for income taxes | 21,185 | (41,539 | ) | 12,717 | (58,811 | ) | |||||||||
| (Benefit) provision for income taxes | (621 | ) | 173 | (621 | ) | 173 | |||||||||
| Net income (loss) | $ | 21,806 | $ | (41,712 | ) | $ | 13,338 | $ | (58,984 | ) | |||||
| Preferred stock dividends | $ | (319 | ) | $ | (319 | ) | $ | (1,265 | ) | $ | (1,269 | ) | |||
| Net income (loss) attributable to common stockholders | $ | 21,487 | $ | (42,031 | ) | $ | 12,073 | $ | (60,253 | ) | |||||
| Net income (loss) per share, basic | $ | 0.29 | $ | (0.57 | ) | $ | 0.16 | $ | (0.82 | ) | |||||
| Net income (loss) per share, diluted | $ | 0.28 | $ | (0.57 | ) | $ | 0.16 | $ | (0.82 | ) | |||||
| Weighted-average shares outstanding, basic | 74,778 | 73,835 | 74,507 | 73,482 | |||||||||||
| Weighted-average shares outstanding, diluted | 76,536 | 73,835 | 75,663 | 73,482 | |||||||||||
CONSOLIDATED BALANCE SHEETS (unaudited, in thousands, except par value) | |||||||
ASSETS | |||||||
| Current Assets: | |||||||
| Cash and cash equivalents | $ | 23,415 | $ | 35,469 | |||
| Restricted cash | 2,258 | 742 | |||||
| Accounts receivable, net | 55,069 | 58,217 | |||||
| Inventories | 61,676 | 49,914 | |||||
| Derivative instruments | 525 | 3,313 | |||||
| Transferable tax credits, net | 7,500 | — | |||||
| Other current assets | 5,474 | 5,463 | |||||
| Total current assets | 155,917 | 153,118 | |||||
| Property and equipment, net | 198,501 | 214,742 | |||||
| Other Assets: | |||||||
| Right of use operating lease assets, net | 16,931 | 20,553 | |||||
| Intangible assets, net | 7,574 | 4,509 | |||||
| Other assets | 9,863 | 8,516 | |||||
| Total other assets | 34,368 | 33,578 | |||||
| Total Assets | $ | 388,786 | $ | 401,438 | |||
CONSOLIDATED BALANCE SHEETS (CONTINUED) (unaudited, in thousands, except par value) | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | December 31, 2025 | December 31, 2024 | |||||
| Current Liabilities: | |||||||
| Accounts payable | $ | 14,509 | $ | 20,369 | |||
| Accrued liabilities | 16,691 | 24,214 | |||||
| Current portion – long-term debt | 16,600 | — | |||||
| Current portion – operating leases | 4,958 | 4,851 | |||||
| Derivative instruments | 1,067 | 1,177 | |||||
| Other current liabilities | 5,246 | 7,193 | |||||
| Total current liabilities | 59,071 | 57,804 | |||||
| Long-term debt, net | 63,027 | 92,904 | |||||
| Operating leases, net of current portion | 13,012 | 16,913 | |||||
| Other liabilities | 8,435 | 8,754 | |||||
| Total Liabilities | 143,545 | 176,375 | |||||
| Stockholders’ Equity: | |||||||
| Preferred stock, Series A: no shares issued and outstanding as of Series B: 927 shares issued and outstanding as of | 1 | 1 | |||||
| Common stock, | 77 | 77 | |||||
| Non-voting common stock, | — | — | |||||
| Additional paid-in capital | 1,051,795 | 1,044,176 | |||||
| Accumulated other comprehensive income | 5,461 | 4,975 | |||||
| Accumulated deficit | (812,093 | ) | (824,166 | ) | |||
| Total Stockholders’ Equity | 245,241 | 225,063 | |||||
| Total Liabilities and Stockholders’ Equity | $ | 388,786 | $ | 401,438 | |||
| Reconciliation of Adjusted EBITDA to Net Income (Loss) | |||||||||||||||
| Three Months Ended | Years Ended | ||||||||||||||
| (in thousands) (unaudited) | 2025 | 2024 | 2025 | 2024 | |||||||||||
| Net income (loss) | $ | 21,806 | $ | (41,712 | ) | $ | 13,338 | $ | (58,984 | ) | |||||
| Adjustments: | |||||||||||||||
| Interest expense, net | 2,425 | 2,474 | 10,765 | 7,644 | |||||||||||
| Interest income | (175 | ) | (112 | ) | (381 | ) | (689 | ) | |||||||
| Unrealized derivative (gains) losses | 4,036 | (5,495 | ) | 2,679 | (13,574 | ) | |||||||||
| Excess insurance proceeds | (6,688 | ) | — | (6,688 | ) | — | |||||||||
| Acquisition-related expenses (recoveries) | — | 5,676 | (460 | ) | 7,701 | ||||||||||
| (Benefit) provision for income taxes | (621 | ) | 173 | (621 | ) | 173 | |||||||||
| Asset impairments | 803 | 24,790 | 803 | 24,790 | |||||||||||
| Depreciation and amortization expense | 6,328 | 6,548 | 25,216 | 24,408 | |||||||||||
| Total adjustments | 6,108 | 34,054 | 31,313 | 50,453 | |||||||||||
| Adjusted EBITDA | $ | 27,914 | $ | (7,658 | ) | $ | 44,651 | $ | (8,531 | ) | |||||
| Segment Financials (unaudited, in thousands) | |||||||||||||||
| Three Months Ended | Years Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Pekin Campus, recorded as gross: | |||||||||||||||
| Alcohol sales | $ | 105,134 | $ | 100,216 | $ | 415,801 | $ | 415,710 | |||||||
| Essential ingredient sales | 45,108 | 42,011 | 174,598 | 169,308 | |||||||||||
| Intersegment sales | 324 | 316 | 1,088 | 1,243 | |||||||||||
| Total Pekin Campus sales | 150,566 | 142,543 | 591,487 | 586,261 | |||||||||||
| Marketing and distribution: | |||||||||||||||
| Alcohol sales, gross | $ | 55,398 | $ | 37,290 | $ | 221,306 | $ | 216,524 | |||||||
| Intersegment sales | 2,489 | 2,831 | 9,827 | 10,833 | |||||||||||
| Total marketing and distribution sales | 57,887 | 40,121 | 231,133 | 227,357 | |||||||||||
| Western production, recorded as gross: | |||||||||||||||
| Alcohol sales | $ | 17,083 | $ | 41,306 | $ | 67,301 | $ | 115,389 | |||||||
| Essential ingredient sales | 7,476 | 12,769 | 31,552 | 36,953 | |||||||||||
| Intersegment sales | 416 | — | 1,697 | (122 | ) | ||||||||||
| Total Western production sales | 24,975 | 54,075 | 100,550 | 152,220 | |||||||||||
| Corporate and other | 1,766 | 2,755 | 7,369 | 11,374 | |||||||||||
| Intersegment eliminations | (3,229 | ) | (3,147 | ) | (12,612 | ) | (11,954 | ) | |||||||
| Net sales as reported | $ | 231,965 | $ | 236,347 | $ | 917,927 | $ | 965,258 | |||||||
| Cost of goods sold : | |||||||||||||||
| Pekin Campus (1) (2) | $ | 139,712 | $ | 139,899 | $ | 572,134 | $ | 563,033 | |||||||
| Marketing and distribution | 53,190 | 36,348 | 214,095 | 213,023 | |||||||||||
| Western production (1) | 24,931 | 59,449 | 96,897 | 172,209 | |||||||||||
| Corporate and other | 1,240 | 3,592 | 6,689 | 12,285 | |||||||||||
| Intersegment eliminations | (2,271 | ) | (1,550 | ) | (6,801 | ) | (5,014 | ) | |||||||
| Cost of goods sold as reported | $ | 216,802 | $ | 237,738 | $ | 883,014 | $ | 955,536 | |||||||
| Gross profit (loss): | |||||||||||||||
| Pekin Campus | $ | 10,854 | $ | 2,644 | $ | 19,353 | $ | 23,228 | |||||||
| Marketing and distribution | 4,697 | 3,773 | 17,038 | 14,334 | |||||||||||
| Western production | 44 | (5,374 | ) | 3,653 | (19,989 | ) | |||||||||
| Corporate and other | 526 | (837 | ) | 680 | (911 | ) | |||||||||
| Intersegment eliminations | (958 | ) | (1,597 | ) | (5,811 | ) | (6,940 | ) | |||||||
| Gross profit (loss) as reported | $ | 15,163 | $ | (1,391 | ) | $ | 34,913 | $ | 9,722 | ||||||
________________
(1) – includes depreciation and amortization expense
(2) – includes unrealized gain (loss) on derivatives
| Sales and Operating Metrics (unaudited) | |||||||||||||||
| Three Months Ended | Years Ended | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Alcohol Sales (gallons in millions) | |||||||||||||||
| Pekin Campus renewable fuel gallons sold | 29.5 | 32.1 | 122.6 | 125.7 | |||||||||||
| Western production renewable fuel gallons sold | 7.9 | 22.3 | 32.6 | 60.5 | |||||||||||
| Third party renewable fuel gallons sold | 25.7 | 19.0 | 106.9 | 108.3 | |||||||||||
| Total renewable fuel gallons sold | 63.1 | 73.4 | 262.1 | 294.5 | |||||||||||
| Specialty alcohol gallons sold | 21.4 | 21.7 | 88.0 | 91.5 | |||||||||||
| Total gallons sold | 84.5 | 95.1 | 350.1 | 386.0 | |||||||||||
| Sales Price per Gallon | |||||||||||||||
| Pekin Campus | $ | 2.09 | $ | 1.89 | $ | 2.00 | $ | 1.95 | |||||||
| Western production | $ | 2.16 | $ | 1.86 | $ | 2.06 | $ | 1.91 | |||||||
| Marketing and distribution | $ | 2.15 | $ | 1.96 | $ | 2.07 | $ | 2.00 | |||||||
| Total | $ | 2.10 | $ | 1.88 | $ | 2.02 | $ | 1.95 | |||||||
| Alcohol Production (gallons in millions) | |||||||||||||||
| Pekin Campus | 54.5 | 55.4 | 215.3 | 212.4 | |||||||||||
| Western production | 8.1 | 21.2 | 32.9 | 58.7 | |||||||||||
| Total | 62.6 | 76.6 | 248.2 | 271.1 | |||||||||||
| Corn Cost per Bushel | |||||||||||||||
| Pekin Campus | $ | 4.22 | $ | 4.17 | $ | 4.54 | $ | 4.45 | |||||||
| Western production | $ | 5.47 | $ | 5.79 | $ | 5.62 | $ | 5.73 | |||||||
| Total | $ | 4.38 | $ | 4.63 | $ | 4.68 | $ | 4.72 | |||||||
| Average | |||||||||||||||
| PLATTS Ethanol price per gallon | $ | 1.77 | $ | 1.60 | $ | 1.76 | $ | 1.69 | |||||||
| CME Corn cost per bushel | $ | 4.31 | $ | 4.26 | $ | 4.39 | $ | 4.24 | |||||||
| Board corn crush per gallons (1) | $ | 0.23 | $ | 0.08 | $ | 0.19 | $ | 0.18 | |||||||
| Essential Ingredients Sold (thousand tons) | |||||||||||||||
| Pekin Campus: | |||||||||||||||
| Distillers grains | 85.4 | 85.3 | 337.6 | 336.4 | |||||||||||
| CO2 | 46.2 | 52.7 | 192.2 | 188.6 | |||||||||||
| Corn wet feed | 21.2 | 41.4 | 107.3 | 121.8 | |||||||||||
| Corn dry feed | 34.6 | 22.0 | 106.9 | 87.2 | |||||||||||
| Corn oil and germ | 20.0 | 21.0 | 78.0 | 75.1 | |||||||||||
| Syrup and other | 6.7 | 10.0 | 36.4 | 38.6 | |||||||||||
| Corn meal | 9.3 | 9.3 | 36.8 | 35.4 | |||||||||||
| Yeast | 5.9 | 5.4 | 24.4 | 23.2 | |||||||||||
| Total Pekin Campus essential ingredients sold | 229.3 | 247.1 | 919.6 | 906.3 | |||||||||||
| Western production: | |||||||||||||||
| Distillers grains | 56.1 | 144.3 | 235.3 | 394.5 | |||||||||||
| CO2 | 13.5 | 14.6 | 56.5 | 57.7 | |||||||||||
| Syrup and other | 0.8 | 17.2 | 3.5 | 54.8 | |||||||||||
| Corn oil | 1.1 | 3.1 | 4.3 | 7.6 | |||||||||||
| Total Western production essential ingredients sold | 71.5 | 179.2 | 299.6 | 514.6 | |||||||||||
| Total Essential Ingredients Sold | 300.8 | 426.3 | 1,219.2 | 1,420.9 | |||||||||||
| Essential ingredients return % (2) | |||||||||||||||
| Pekin Campus return | 53.1% | 49.5% | 49.3% | 49.7% | |||||||||||
| Western production return | 48.3% | 30.3% | 50.4% | 32.0% | |||||||||||
| Consolidated total return | 52.4% | 43.1% | 49.5% | 45.2% | |||||||||||
________________
(1) Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.
(2) Essential ingredients revenues as a percentage of total corn costs consumed.
Source: 